Skip to main content
    C

    Cardlytics Inc (CDLX)

    Official site

    COMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ

    $1.29
    -0.05 (-3.73%)

    Market Cap: $8.18M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Cardlytics Inc (CDLX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Cardlytics reported revenue of $233.27M for the fiscal year ended Dec 31, 2025, down 16.2% from the year before. That year, net income was -$103.49M with a net margin of -44.4%, operating cash flow was $9.29M and free cash flow was -$6.49M. The quarter ended Sep 30, 2026 had revenue of $32.88M and net income of -$8.95M.

    Revenue and Margins

    The operating margin was -43.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $112.82M, a compound annual rate of 8.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$233.27M-16.2%100.0%-43.6%-44.4%
    Dec 2024$278.30M-10.0%100.0%-70.2%-68.0%
    Dec 2023$309.20M+3.6%100.0%-43.9%-43.6%
    Dec 2022$298.54M+11.8%100.0%-153.3%-155.8%
    Dec 2021$267.12M+42.9%100.0%-45.9%-48.1%
    Dec 2020$186.89M-11.2%100.0%-28.9%-29.7%
    Dec 2019$210.43M+39.6%100.0%-8.2%-8.1%
    Dec 2018$150.68M+15.6%100.0%-27.2%-35.2%
    Dec 2017$130.37M+15.6%100.0%-13.1%-15.1%
    Dec 2016$112.82MN/A100.0%-49.8%-67.1%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$233.27M$278.30M$309.20M$298.54M$267.12M$186.89M$210.43M$150.68M$130.37M$112.82M
    Gross profit$233.27M$278.30M$309.20M$298.54M$267.12M$186.89M$210.43M$150.68M$130.37M$112.82M
    Research and development$39.77M$49.61M$51.35M$54.44M$38.10M$17.53M$11.70M$16.21M$12.15M$13.90M
    Operating income-$101.82M-$195.50M-$135.67M-$457.78M-$122.60M-$53.92M-$17.32M-$40.92M-$17.10M-$56.23M
    Net income-$103.49M-$189.30M-$134.70M-$465.26M-$128.56M-$55.42M-$17.14M-$53.04M-$19.64M-$75.70M
    EBITDA-$66.64M-$167.26M-$101.20M-$418.82M-$73.95M-$33.39M-$11.97MN/A$701.00KN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$32.88M$36.88M$34.32M$56.09M$46.96M$58.04M$56.44M$74.00M$67.06M$69.64M$67.61M$89.17M
    Gross profit$32.88M$36.88M$34.32M$56.09M$46.96M$58.04M$56.44M$74.00M$67.06M$69.64M$67.61M$89.17M
    Operating income-$5.42M-$5.44M-$8.27M-$6.09M-$66.45M-$9.57M-$11.12M-$8.31M-$148.55M-$15.81M-$22.83M-$102.92M
    Net income-$8.95M-$14.88M-$4.48M-$8.25M-$72.67M-$9.28M-$13.28M-$15.59M-$145.18M-$4.26M-$24.27M-$100.84M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $210.53M exceeded cash and equivalents by $161.81M. Shareholder equity was negative, at -$6.51M, as total liabilities of $292.15M exceeded total assets of $285.64M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$285.64M$392.71M$574.14M$691.24M$1.26B$422.54M$224.31M$153.76M$100.76M$86.86M
    Current assets$137.28M$177.98M$223.93M$250.04M$358.73M$385.59M$195.73M$124.37M$74.63M$68.32M
    Cash and equivalents$48.72M$65.59M$91.83M$121.91M$233.47M$293.24M$104.46M$39.62M$21.26M$22.84M
    Total liabilities$292.15M$322.72M$439.35M$479.63M$573.10M$265.35M$81.05M$101.79M$113.01M$303.69M
    Short-term debt$1.61M$45.86M$0$4.91M$6.03M$4.72M$24.00K$21.00K$44.00K$99.00K
    Long-term debt$208.92M$167.73M$257.50M$226.05M$184.40M$174.01M$13.00K$46.69M$56.97M$111.70M
    Shareholder equity-$6.51M$69.99M$134.80M$211.60M$690.70M$157.19M$143.27M$51.98M-$208.69M-$216.84M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$228.51M$234.78M$263.91M$285.64M$292.81M$361.13M$369.07M$392.71M$399.39M$534.37M$568.95M$574.14M
    Total liabilities$251.54M$250.79M$267.91M$292.15M$297.51M$302.43M$304.98M$322.72M$329.70M$324.34M$369.81M$439.35M
    Cash and equivalents$29.95M$28.04M$35.67M$48.72M$43.96M$46.74M$52.05M$65.59M$66.99M$71.25M$97.77M$91.83M
    Shareholder equity-$23.02M-$16.00M-$4.00M-$6.51M-$4.70M$58.71M$64.09M$69.99M$69.70M$210.03M$199.14M$134.80M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$9.29M-$8.82M-$185.00K-$53.90M-$38.52M-$7.60M$11.46M-$19.00M-$22.10M-$32.50M
    Capital expenditures$15.78M$19.30M$12.39M$13.31M$12.43M$10.04M$10.99M$7.32M$1.59M$2.47M
    Free cash flow-$6.49M-$28.12M-$12.58M-$67.22M-$50.95M-$17.64M$468.00K-$26.31M-$23.69M-$34.97M
    Share repurchases$0$309.00K$0$40.16M$190.00K$0$196.00K$1.95M$2.67M$1.67M
    Investing cash flow-$15.30M-$18.75M-$10.06M-$15.76M-$506.69M-$10.12M-$11.02M-$7.34M-$1.65M-$2.54M
    Financing cash flow-$11.12M$1.44M-$20.03M-$39.99M$486.00M$206.43M$44.18M$65.19M$21.76M$30.81M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$5.90M-$8.60M-$5.64M$13.01M$1.76M$1.23M-$6.71M$2.98M$1.39M$4.43M-$17.62M$2.93M
    Capital expenditures$2.20M$2.10M$2.30M$2.56M$4.46M$4.66M$4.10M$4.44M$5.26M$4.86M$4.75M$3.70M
    Free cash flow-$8.10M-$10.70M-$7.95M$10.45M-$2.70M-$3.43M-$10.81M-$1.46M-$3.87M-$429.00K-$22.36M-$763.00K
    Last 12 quarters

    Frequently Asked Questions About CDLX

    What is Cardlytics' annual revenue?

    Cardlytics reported revenue of $233.27M for the fiscal year ended Dec 31, 2025.

    How fast is Cardlytics' revenue growing?

    Revenue was down 16.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -7.9%.

    Is Cardlytics profitable?

    No. Cardlytics reported net income of -$103.49M for the fiscal year ended Dec 31, 2025, with a net margin of -44.4%.

    How much free cash flow does CDLX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $9.29M minus capital expenditures of $15.78M produced free cash flow of -$6.49M.

    How much debt does Cardlytics have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $208.92M, short-term debt of $1.61M and cash and equivalents of $48.72M.